Share Prices & Company Research

Stockbroking

Assura Plc

Current Price 47.68p Bid 46.58p Ask 48.72p Change 0.00%
Last Updated: 14/12/2025 21:15. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Assura plc is a United Kingdom-based real estate investment trust (REIT). The Company specializes in the development of, investment in and management of a portfolio of primary care, diagnostic and treatment buildings across the United Kingdom. It develops new buildings, invests in existing buildings, manages portfolios, and ultimately, owns them for the long term. It also designs, builds, invests in, and manages GP surgery, primary care and community healthcare buildings so the NHS has the places and spaces it needs to deliver more services, tests and treatments in the community. The Company is a long-term property partner to more than 600 medical centers.

Financial Highlights Year Ended 31/03/2025

Revenue
£183.80m
Operating Profit/Loss
£208.10m
Dividend yield (%)
7.20
Total dividend for year
n/ap
Dividend cover
1.05
P/E Ratio
13.20
More Financials

Key Personnel

Mr Jonathan Murphy
Chief Executive Officer
Mrs Jayne Cottam
Chief Financial Officer
Mr Aamir Aziz
Director
Dr Sam Barrell
Non-Executive Director
Mr Jonathan Davies
Non-Executive Director
Mr Noel Gordon
Non-Executive Director
Ms Emma Cariaga
Non-Executive Director
Ms Louise Fowler
Non-Executive Director

Stock Details

EPIC
AGRL
ISIN
GB00BVGBWW93
Shares in Issue
1,637.71m
Market cap
£780.86m

Analyst Views (2)

Strong Buy
 
0%
Buy
 
50.00%
Hold
 
50.00%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
47.68p
Bid Price
46.58p
Ask Price
48.72p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
47.68p
Previous Close
47.68p
Intraday High
47.68p
Intraday Low
47.68p
52 Week High
50.65p
52 Week Low
35.52p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

More Charts

News

Assura delivers 'strong trading performance' in H1 30/09/2025 07:13:22 CMA launches formal probe into PHP-Assura merger 03/09/2025 09:11:05 Director dealings: Assura non-executive director sells shares 21/08/2025 15:35:58 Takeover target Assura swings to annual profit 21/07/2025 07:04:21 London close: Stocks finish lower amid Middle East jitters 23/06/2025 17:44:14 Assura accepts rival bid £1.79bn from PHP in latest takeover twist 23/06/2025 07:02:57 Primary Health Properties defends its Assura bid over Sana offer 13/06/2025 10:56:52 London close: Stocks rise on US CPI, China trade deal 11/06/2025 17:11:05 PHP urges Assura shareholders to take no action on KKR offer 11/06/2025 15:10:48 PHP still 'best option' for Assura despite new KKR bid, says Shore Capital 11/06/2025 09:16:13 Assura accepts increased £1.7bn bid from KKR/Stonepeak 11/06/2025 07:02:43 Assura says PHP offer due diligence still ongoing 06/06/2025 08:00:44 Assura considering PHP bid, postpones shareholder vote 23/05/2025 08:44:41 KKR-backed acquisition vehicel reiterates its bid for Assura 19/05/2025 07:23:29 PHP makes third offer for Assura at £1.68bn, trumps KKR and Stonepeak 16/05/2025 13:47:00 Primary Health Properties still the preferred bidder for Assura, says Shore Capital 09/05/2025 13:18:23 London close: Stocks fall as China retaliates to latest US tariffs 09/04/2025 15:07:28 Assura rejects £1.5bn merger offer from PHP 09/04/2025 07:27:08 London close: Stocks slide in global reaction to Trump tariffs 03/04/2025 15:29:13 Primary Health Properties offers £1.5bn to merge with Assura 03/04/2025 07:27:50 KKR, Stonepeak bid deadline for Assura extended 14/03/2025 15:01:15 Assura 'minded to recommend' improved takeover proposal from KKR, Stonepeak 10/03/2025 07:02:58 KKR's £1.6bn takeover proposal 'materially' undervalues the group, says Assura 18/02/2025 08:12:08 KKR assessing options after Assura rejects four takeover bids 17/02/2025 07:22:43 Assura makes progress with disposals, developments 09/01/2025 10:00:55

Income Statement

Year End Date
31 Mar 2025
31 Mar 2024
 
£ (M)
£ (M)
Continuing Operations
Revenue
183.80
157.80
Operating Profit/Loss
208.10
-1.50
Net Interest
-42.10
-27.20
Pre-Tax Profit
166.00
-28.70
Profit After Tax from continuing operations
166.00
-28.70
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
166.00
-28.70
Attributable to:
Equity Holders of Parent Company
166.00
-28.70
Minority Interests
n/a
n/a
Total Dividend Paid
n/ap
n/ap
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
31 Mar 2025
31 Mar 2024
Basic
5.30p
-1.00p
Diluted
5.30p
-1.00p
Adjusted
3.50p
3.40p
Dividend per Share
n/ap
n/ap

Assets

Year End Date
31 Mar 2025
31 Mar 2024
 
£ (M)
£ (M)
Non-Current Assets
Property, Plant & Equipment
11.10
10.50
Intangible Assets
n/a
n/a
Investment Properties
3,099.10
2,708.30
Investments
53.40
19.70
Other Financial Assets
n/a
n/a
Other Non-Current Assets
0.70
0.60
Current Assets
Inventories
n/a
n/a
Trade & Other Receivables
40.90
37.30
Cash at Bank & In Hand
58.10
35.40
Current Asset Investments
n/a
n/a
Other Current Assets
18.10
0.40
Other Assets
n/a
n/a
Total Assets
3,281.40
2,812.20

Liabilities

Year End Date
31 Mar 2025
31 Mar 2024
 
£ (M)
£ (M)
Current Liabilities
Borrowings
70.10
0.30
Other Current Liabilities
90.20
82.10
Total Current Liabilities
160.30
82.40
Non-Current Liabilities
Borrowings
1,474.80
1,252.50
Provisions
3.80
4.20
Other Non-Current Liabilities
0.10
n/a
Total Non-Current Liabilities
1,478.70
1,256.70
Other Liabilities
n/a
n/a
Total Liabilities
1,639.00
1,339.10

Net Assets

Year End Date
31 Mar 2025
31 Mar 2024
 
£ (M)
£ (M)
Net Assets
1,642.40
1,473.10

Capital & Reserves

Year End Date
31 Mar 2025
31 Mar 2024
 
£ (M)
£ (M)
Share Capital
325.10
298.50
Share Premium Account
1,013.60
932.70
Other Reserves
230.20
231.00
Retained Earnings
73.50
10.90
Shareholders Funds
1,642.40
1,473.10
Minority Interests/Other Equity
n/a
n/a
Total Equity
1,642.40
1,473.10

Dividend History

Type
Ex-Dividend Date
Payment Date
Payment
Special
12 Aug 2025
26 Aug 2025
0.84p
Q1
05 Jun 2025
09 Jul 2025
0.84p
Q4
06 Mar 2025
09 Apr 2025
0.84p
Q3
12 Dec 2024
15 Jan 2025
0.84p
Q2
05 Sep 2024
09 Oct 2024
0.84p
Q1
06 Jun 2024
10 Jul 2024
0.84p
Q4
07 Mar 2024
10 Apr 2024
0.82p
Q3
07 Dec 2023
10 Jan 2024
0.82p
Q2
07 Sep 2023
11 Oct 2023
0.82p
Q1
07 Jun 2023
12 Jul 2023
0.82p
Q1
08 Jun 2023
12 Jul 2023
0.82p
Q4
09 Mar 2023
12 Apr 2023
0.78p
Q3
08 Dec 2022
11 Jan 2023
0.78p
Q2
08 Sep 2022
12 Oct 2022
0.78p
Q1
09 Jun 2022
13 Jul 2022
0.78p
Q4
10 Mar 2022
13 Apr 2022
0.74p
Q3
09 Dec 2021
12 Jan 2022
0.74p
Q2
09 Sep 2021
13 Oct 2021
0.74p
Q1
10 Jun 2021
14 Jul 2021
0.74p
Q4
11 Mar 2021
14 Apr 2021
0.71p
Q3
10 Dec 2020
13 Jan 2021
0.71p
Q2
10 Sep 2020
14 Oct 2020
0.71p
Q1
11 Jun 2020
15 Jul 2020
0.71p
Q4
12 Mar 2020
15 Apr 2020
0.697p
Q3
12 Dec 2019
15 Jan 2020
0.697p
Q2
12 Sep 2019
16 Oct 2019
0.685p
Q1
13 Jun 2019
17 Jul 2019
0.685p
Q4
14 Mar 2019
17 Apr 2019
0.685p
Q3
13 Dec 2018
16 Jan 2019
0.685p
Q2
13 Sep 2018
17 Oct 2018
0.655p
Q1
14 Jun 2018
18 Jul 2018
0.655p
Q4
15 Mar 2018
18 Apr 2018
0.655p
Q3
14 Dec 2017
17 Jan 2018
0.655p
Q2
14 Sep 2017
18 Oct 2017
0.60p
Q1
15 Jun 2017
19 Jul 2017
0.60p
Q4
16 Mar 2017
19 Apr 2017
0.60p
Q3
15 Dec 2016
18 Jan 2017
0.60p
Q2
15 Sep 2016
19 Oct 2016
0.55p
Q1
23 Jun 2016
27 Jul 2016
0.60p
Q4
17 Mar 2016
20 Apr 2016
0.55p
Q3
17 Dec 2015
20 Jan 2016
0.55p
Q2
22 Oct 2015
04 Nov 2015
0.50p
Q1
09 Jul 2015
22 Jul 2015
0.50p
Q4
16 Apr 2015
30 Apr 2015
0.50p
Q3
08 Jan 2015
21 Jan 2015
0.50p
Q2
23 Oct 2014
05 Nov 2014
0.45p
Q1
09 Jul 2014
23 Jul 2014
0.45p

Dividend Metrics

Year End Date
31 Mar 2025
31 Mar 2024
Dividend growth
3.09%
5.19%
Dividend yield
7.20%
7.60%
Dividend cover
1.05
1.05


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.